Publications by authors named "Ioanna G Saougou"
Article Synopsis
- Juvenile idiopathic arthritis (JIA) is a chronic inflammatory condition affecting children under 16, characterized by arthritis lasting more than 6 weeks, with no current cure available.
- While traditional treatments included non-steroidal medications and corticosteroids, recent advancements in biologic therapies have significantly improved patient outcomes by enhancing function, reducing pain, and preventing joint damage.
- International organizations like the American College of Rheumatology have developed guidelines for rheumatologists, further revolutionizing JIA management and providing a more hopeful future for affected individuals.
Objective: To identify male patients who were treated with infliximab and had fathered healthy newborns during their management.
Methods: We reviewed medical records of men with ankylosing spondylitis (AS) who were followed up at the Rheumatology Outpatients clinic and were treated with infliximab during the period 2001-2007.
Results: We identified 4 patients with AS who had fathered 6 healthy children during infliximab treatment.